mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.07 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |